{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihgtbixrf4ondev6tgvfnsciefdyzthad3kqwbxekpnylutpmruxu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjhqfxddqbg2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieekinwjzv6fyihuyb6c67rr7pkgrpmz5o37hn45nl2swskrl3c3e"
    },
    "mimeType": "image/jpeg",
    "size": 608428
  },
  "path": "/news/2026-04-combining-drug-chemotherapy-survival-platinum.html",
  "publishedAt": "2026-04-14T10:20:08.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases. In some patients, the disease returns or progresses within six months of the last platinum dose, a condition referred to as platinum-resistant cancer. This form of cancer is a leading cause of gynecological cancer-related mortality.",
  "title": "Combining new drug with chemotherapy extends survival of platinum-resistant ovarian cancer patients in clinical trial"
}